advertisement
Kim SJ 20
Showing records 1 to 20 | Display all abstracts from Kim SJ106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Ahmed A
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Sit AJ
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Lee JH; Kwon YJ
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Chen TC
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Aziz M
Biomolecules 2022; 12:
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Lee HS
Nutrients 2022; 14:
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Ejaz SA
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Takusagawa HL; Rosdahl JA
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Channar PA
Biomolecules 2022; 12:
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Han JH
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Hoguet A
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Joung B
Nutrients 2022; 14:
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Saeed A; Zargar S
Biomolecules 2022; 12:
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Kim SJ
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Chopra V; Richter GM
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Wani TA; Hamad A
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Ou Y
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Abbas Q
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology
Kim SJ; WuDunn D
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer
Raza H; Kim SJ
Biomolecules 2022; 12:
